FdaApplication
BLA 761248
Identifiers
- fda_app_no: BLA761248
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 2024-07-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| KISUNLA | DONANEMAB-AZBT | 350MG/20ML (17.5MG/ML) | Injection |
1 product